Lynda Charters; Reviewed by Dr Ramin Khoramnia


IRISS registry study offers real-world outcomes

Investigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.

Sally Tucker


ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World Leaders

OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.

Dr David A. Eichenbaum


Repeatable, high-quality imaging leads to better diabetic eye disease management

SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.

Dr Peter Y. Chang


Current approaches to treatment of uveitis with autoimmune disease

Underlying autoimmune disease alters uveitis therapy.

Dr Alain Bron


Personalising glaucoma surgery: The role of MIGS

Minimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.

Terry Lee, MD


Retinal imaging to detect Alzheimer disease: machine learning model

An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.

Rod McNeil; Reviewed by Dr David S. Boyer, Prof. Ramin Tadayoni, Dr Jeffrey S. Heier and Dr Paul Hahn


Brolucizumab for neovascular AMD: Safety guidance and clinician perspectives

Although the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits.

Dr Juan David Arias


Using swept-source OCT and OCT angiography to image choroidal tumours

SS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.

By Lynda Charters; reviewed by Tsontcho Ianchulev, MD, MPH


AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGS

Investigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures

Dr Amir Rosenblatt


Assessing barriers to retinal care during a pandemic

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.

Dr Inder Paul Singh
Dr Inder Paul Singh


Simplifying glaucoma medical therapy for patients in the United States

Compounded medications are playing a central role in the process.

Dr Jorge L. Alió and Dr Elinor Megiddo-Barnir


Extended depth-of-focus IOLs: A review

A look at how EDOF technology can be categorised into five types

Dr Rishi Raj Borah


Orbis brings school-based eye health intervention to children in India

The nonprofit's Refractive Error Among Children programme allows for early detection, prevention and appropriate management of visual impairment.

Michael W. Stewart, MD


Letter to the Editor: Intravitreal injections. Who should perform them?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.

Dr Frank J. Goes


Half a century of developments in ophthalmology: One doctor’s reflections

Dr Goes reflects on a life at the forefront of ophthalmology, considering advancements in technology and the knowledge that has changed his practice and improved outcomes for patients.

Kassi Jackson


US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents

Louise Gagnon; Reviewed by Dr Rachel Curtis


Smartphone direct ophthalmoscope tech helps visualise optic disc

A smartphone direct ophthalmoscope attachment makes it possible to examine the optic nerve and distinguish whether its state of health is normal or abnormal.

Benson S. Chen, MBChB, MSc, FRACP


The ins and outs of gene therapy for inherited optic neuropathies

A look at what’s in the therapeutic delivery pipeline for these disorders.

Prof. Jorge Alio


Cosmetic surgery of the cornea: A new type of surgery

A colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.

Mr Mayank A. Nanavaty


Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.

Dr Lisa M. Nijm


Rethinking dry eye disease with acute steroid treatment

Loteprednol etabonate suspension 0.25% demonstrates anti-inflammatory action and produces significant improvement in conjunctival hyperaemia and ocular discomfort.

Dr Hasan Naveed


Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.

Prof István Szabó


Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.

Elana Meer, BA


Electronic health records: how the pandemic highlighted the future of practice management

Electronic health records may be the future of practice management.

Marco Zarbin, MD, PhD, FACS


Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trials in nAMD

Dr Marco Zarbin presents his talk from the 2023 ASRS annual meeting, where he explores the impact of disease activity criteria on drug durability estimations in clinical trials and includes a comparative analysis across multiple clinical trials in neovascular AMD (age-related macular degeneration).

Dr Marta Ibarz Barberá


Benefits of topography-guided treatments for irregular corneas

Topography-guided treatments for irregular corneas can improve patients’ best corrected visual acuity. The technique is easy to plan and perform, supported by software to do the calculations.

© 2024 MJH Life Sciences

All rights reserved.